IL32 and breast carcinoma: These effects are also observed in animal models of malignant tumors: recombinant NK4 suppressed the primary tumor growth, metastasis of Lewis lung carcinoma, and Jyg-MC(A) mammary carcinoma in mice [54], although neither HGF nor NK4 affected proliferation and survival of these tumor cells in vitro.